Search

everythinglearnresearchcommunity

for

Search:↓

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Tridax procumbens significantly lowers blood sugar in diabetic rats.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

GLP-1 receptor agonists can help skin conditions but may cause hair loss and other skin issues.

Weight-loss drugs are not linked to suicidal thoughts.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Finasteride may worsen blood sugar control in diabetic patients.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

More research is needed to understand if GLP-1 agonists affect hair health.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Lifestyle changes are more effective than medication for managing PCOS-related risks.

GLP-1 receptor analogs may help improve metabolism and reproductive health in people with PCOS and obesity.

GLP-1 receptor agonists for weight loss may cause hair loss, especially in women.

Finasteride and bicalutamide can affect blood sugar, so diabetics need monitoring.

Finasteride and bicalutamide can affect blood sugar, so diabetics need monitoring.

GLP-1RA therapy may increase the risk of hair loss.

Newer GLP-1 drugs like semaglutide may cause hair loss.

Troglitazone increases subcutaneous fat in lipodystrophy patients.

Switching insulin brands caused skin lesions in a diabetic woman, resolved by changing to oral medication.

GLP-1 receptor agonists help women with PCOS lose weight and improve health, but more research is needed on long-term effects.

Tirzepatide may improve hair loss by reducing insulin resistance.